HOME >> BIOLOGY >> NEWS
'Trap' crop saves Texas cross timbers melon production

STEPHENVILLE -- Mark Allison, Comanche County farmer, first noticed a few yellow vines in his watermelon crop in the late 1990s but didn't think much of it.

There are a number of diseases that cause melon vines to yellow, but this one thumbed its nose at conventional treatments. The next year, it struck again, turning half his crop into a mass of yellow, wilted heap of vines, leaves and unmarketable fruit.

At war with diseases, often besieged by unpredictable weather, melon farming is a high-investment, high-risk crop. With tens of thousands of dollars in production costs at stake, Allison called his first line of defense, Bob Whitney, Texas Cooperative Extension agent for Comanche County.

Whitney brought in Dr. Forrest Mitchell, a Texas Agricultural Experiment Station entomologist. Mitchell, who is based at the Texas A&M University System Agricultural Research and Extension Center at Stephenville, got right to work. Mitchell had been involved in the hunt for the cause of yellow vine disease since the mid 1990s.

In 1991, yellow vine disease made its premier performance in Texas and Oklahoma, striking melon and cantaloupe fields with a vengeance. Some fields were completely wiped out. By the mid-1990s, it was clear the melon industry throughout the region was at risk.

In response to the threat, Mitchell joined a multi-disciplinary task force that included Texas A&M System scientists, U.S. Department of Agriculture scientists at Lane, Okla., and Oklahoma State University researchers. Work proceeded on various fronts, as some theories about the disease were proven and others discarded.

For example, in 1997, Mitchell and his colleagues at the Stephenville center were the first to positively identify a rod-shaped cell bacterium-like organism that was at work in yellow vine disease.

The scientists knew an insect had to be spreading the disease, but which one remained a mystery for some time. At first the chief suspect wa
'"/>

Contact: Robert Burns
903-834-6191
Texas A&M University - Agricultural Communications
7-Jul-2004


Page: 1 2 3 4

Related biology news :

1. Disease-resistant papaya saves Hawaiian papaya industry
2. Salmonella infects cells and saves itself by altering host membrane lipids
3. Busy sequencing technique saves money and time
4. Common asthma drug saves patients money, trips to hospital
5. Dead zone area shrinking, Texas A&M prof says
6. Hardy buoys: Texas A&M project predicts oil spill movements
7. Water on Mars not easy to find, says Texas A&M researcher
8. Weed from hell found in Texas
9. Global competition closes Texas sawmills/paper mills
10. Fire ant killing protozoa found in 120 Texas counties
11. Tiny beetle wreaks havoc on Texas ornamental tree nurseries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused ... Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine ... and is expected to deliver therapeutic levels of olanzapine for a period of 3 ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
Breaking Biology Technology:
Cached News: